Page last updated: 2024-08-23

nicorandil and Non-alcoholic Fatty Liver Disease

nicorandil has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdallah, H; Abdel Maksoud, OM; Bastawy, N; Ibrahim, W; Morsi, H; Rashed, LA; Soliman, GF1
Elshazly, SM1

Other Studies

2 other study(ies) available for nicorandil and Non-alcoholic Fatty Liver Disease

ArticleYear
Interrelation of liver vascularity to non-alcoholic fatty liver through a comparative study of the vasodilator effect of carvedilol or nicorandil in rats.
    Life sciences, 2019, Apr-01, Volume: 222

    Topics: Adrenergic beta-Antagonists; Animals; Carvedilol; Liver; Male; Nicorandil; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; Vasodilator Agents

2019
Ameliorative effect of nicorandil on high fat diet induced non-alcoholic fatty liver disease in rats.
    European journal of pharmacology, 2015, Feb-05, Volume: 748

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Blood Glucose; Body Weight; Cholesterol; Cytoprotection; Diet, High-Fat; Drug Interactions; Gene Expression Regulation, Enzymologic; Homeostasis; Insulin; Insulin Resistance; Liver; Male; NF-kappa B; Nicorandil; Nitric Oxide Synthase Type III; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Pioglitazone; Rats; Rats, Wistar; Thiazolidinediones; Triglycerides; Tumor Necrosis Factor-alpha

2015